Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Wednesday.
Kewaunee Scientific Trading Up 3.6 %
Shares of NASDAQ KEQU opened at $54.93 on Wednesday. Kewaunee Scientific has a fifty-two week low of $24.67 and a fifty-two week high of $56.95. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. The company has a market cap of $157.76 million, a price-to-earnings ratio of 8.71 and a beta of 0.80. The business’s 50 day moving average price is $39.37 and its 200-day moving average price is $42.48.
Insider Transactions at Kewaunee Scientific
In other news, VP Elizabeth D. Phillips sold 1,850 shares of the firm’s stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total transaction of $100,214.50. Following the transaction, the vice president now directly owns 13,591 shares of the company’s stock, valued at approximately $736,224.47. This trade represents a 11.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 14.20% of the company’s stock.
Institutional Inflows and Outflows
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Stories
- Five stocks we like better than Kewaunee Scientific
- Trading Stocks: RSI and Why it’s Useful
- Micron Stock Under $100: Seize the AI-Driven Upside
- What is the Australian Securities Exchange (ASX)
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- 3 Monster Growth Stocks to Buy Now
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.